Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands

Daniel R. Morales, Steve V. Morant, Thomas M. MacDonald*, Isla S. Mackenzie, Alexander S. F. Doney, Lyn Mitchell, Marion Bennie, Chris Robertson, Jesper Hallas, Anton Pottegard, Martin Thomsen Ernst, Li Wei, Lizzie Nicholson, Carole Morris, Ron M. C. Herings, Jetty A. Overbeek, Elisabeth Smits, Robert W. V. Flynn

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)
9 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science